Approval · Notice of Compliance 32558 · 2024

LATUDA: Notice of Compliance 32558

Issued January 19, 2024

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 32558
Date: January 19, 2024
Company: Sumitomo Pharma Canada, Inc.Mississauga, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Administrative: Manufacturer Name Change

Products in this notice

Brand	DIN	Status today
LATUDA	02422050	Cancelled Post Market
LATUDA	02387751	Cancelled Post Market
LATUDA	02413361	Cancelled Post Market
LATUDA	02387778	Cancelled Post Market
LATUDA	02387786	Cancelled Post Market

Medicinal ingredients

LURASIDONE HYDROCHLORIDE 20 MG per TAB
LURASIDONE HYDROCHLORIDE 40 MG per TAB
LURASIDONE HYDROCHLORIDE 60 MG per TAB
LURASIDONE HYDROCHLORIDE 80 MG per TAB
LURASIDONE HYDROCHLORIDE 120 MG per TAB